Cabanlit, Judy Ann .

HRN: 28-69-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
AMPICILLIN 1GM (VIAL)
03/17/2026
03/18/2026
IVT
2g
Q6
Prom
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: